Stakeholders ask FDA to expand guidance on streamlining testing of single-target monoclonal antibodies
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesGuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)